UTRGV Schizophrenia Diagnostic Treatment Discussion 1) Discussion 2: Child and Adolescent Disorders Select one disorder of interest from the DSM-5 covered

UTRGV Schizophrenia Diagnostic Treatment Discussion 1) Discussion 2: Child and Adolescent Disorders
Select one disorder of interest from the DSM-5 covered this week. In your initial posting, discuss the diagnostic criteria, treatment options, and prognosis of the disorder. Use at least two current references other than the DSM-5. After you have posted your initial posting by the third day of the module, respond substantively to at least three peers by the end of the module.
the post tmay have at least 3 citation apa

2) two resposes, the resposes are usually aditional infos to the post with at least on e citation.

response one to keyy

“Gender Dysphoria in Children 302.6 (F64.2

A marked incongruence between one’s experienced/expressed gender and assigned gender, of at least 6 months’ duration, as manifested by at least six of the following (one of which must be Criterion A1):
A strong desire to be of the other gender or an insistence that one is the other gender (or some alternative gender different from one’s assigned gender).
In boys (assigned gender), a strong preference for cross-dressing or simulating female attire; or in girls (assigned gender), a strong preference for wearing only typical masculine clothing and a strong resistance to the wearing of typical feminine clothing.
A strong preference for cross-gender roles in make-believe play or fantasy play.
A strong preference for the toys, games, or activities stereotypically used or engaged in by the other gender.
A strong preference for playmates of the other gender.
In boys (assigned gender), a strong rejection of typically masculine toys, games, and activities and a strong avoidance of rough-and-tumble play; or in girls (assigned gender), a strong rejection of typically feminine toys, games, and activities.
A strong dislike of one’s sexual anatomy.
A strong desire for the primary and/or secondary sex characteristics that match one’s experienced gender.
The condition is associated with clinically significant distress or impairment in social, school, or other important areas of functioning.”

Gender dysphoria is a conflict between a person’s biological sex or assigned gender in the gender in which they identify causing stress. For those children and families dealing with established gender dysphoria from participating in a multi-disciplinary assessment gonadotropin-releasing hormone analogue (GnRHa) is a first line medical intervention (Butler, Graaf, Wren, & Carmichael, 2018). This provides a physically reversible option to suspend sex hormone production thereby reducing anxiety of the ongoing physical development allowing for more time for psychotherapeutic interventions and exploration. This treatment is also requested in early puberty, this prevents the bodily characteristics and allows the person to “pass” as the preferred sex (Butler, Graaf, Wren, & Carmichael, 2018).

response two to benson

“Gender Dysphoria in Children 302.6 (F64.2

A marked incongruence between one’s experienced/expressed gender and assigned gender, of at least 6 months’ duration, as manifested by at least six of the following (one of which must be Criterion A1):
A strong desire to be of the other gender or an insistence that one is the other gender (or some alternative gender different from one’s assigned gender).
In boys (assigned gender), a strong preference for cross-dressing or simulating female attire; or in girls (assigned gender), a strong preference for wearing only typical masculine clothing and a strong resistance to the wearing of typical feminine clothing.
A strong preference for cross-gender roles in make-believe play or fantasy play.
A strong preference for the toys, games, or activities stereotypically used or engaged in by the other gender.
A strong preference for playmates of the other gender.
In boys (assigned gender), a strong rejection of typically masculine toys, games, and activities and a strong avoidance of rough-and-tumble play; or in girls (assigned gender), a strong rejection of typically feminine toys, games, and activities.
A strong dislike of one’s sexual anatomy.
A strong desire for the primary and/or secondary sex characteristics that match one’s experienced gender.
The condition is associated with clinically significant distress or impairment in social, school, or other important areas of functioning.”

Gender dysphoria is a conflict between a person’s biological sex or assigned gender in the gender in which they identify causing stress. For those children and families dealing with established gender dysphoria from participating in a multi-disciplinary assessment gonadotropin-releasing hormone analogue (GnRHa) is a first line medical intervention (Butler, Graaf, Wren, & Carmichael, 2018). This provides a physically reversible option to suspend sex hormone production thereby reducing anxiety of the ongoing physical development allowing for more time for psychotherapeutic interventions and exploration. This treatment is also requested in early puberty, this prevents the bodily characteristics and allows the person to “pass” as the preferred sex (Butler, Graaf, Wren, & Carmichael, 2018).

In a recent report by (Cohen & Barnes, 2019) there is conflicting information about these studies for using puberty blocking drugs on these vulnerable patients. Not only is this author reporting missing information on study participants information sheets but now they allege that the researchers might’ve broken rules when seeking ethical approval. This brings into question the appropriate use of puberty blocking drugs for the treatment of gender dysphoria.

Clinical professionals have yet to identifying longitudinal outcomes of treatment. While we may see that psychological support and puberty suppression are both associated with an improved global psychosocial functioning for adolescence, there has been difficulty tracking these individuals (Butler, Graaf, Wren, & Carmichael, 2018).

Butler, G., Graaf, N. D., Wren, B., & Carmichael, P. (2018). Assessment and support of children and adolescents with gender dysphoria. Archives of Disease in Childhood. doi:10.1136/archdischild-2018-314992

Cohen, D., & Barnes, H. (2019). Gender dysphoria in children: Puberty blockers study draws further criticism. Bmj,L5647. doi:10.1136/bmj.l5647

Diagnostic and statistical manual of mental disorders: DSM-5. (2017). Arlington, VA: American Psychiatric Association.

In a recent report by (Cohen & Barnes, 2019) there is conflicting information about these studies for using puberty blocking drugs on these vulnerable patients. Not only is this author reporting missing information on study participants information sheets but now they allege that the researchers might’ve broken rules when seeking ethical approval. This brings into question the appropriate use of puberty blocking drugs for the treatment of gender dysphoria.

Clinical professionals have yet to identifying longitudinal outcomes of treatment. While we may see that psychological support and puberty suppression are both associated with an improved global psychosocial functioning for adolescence, there has been difficulty tracking these individuals (Butler, Graaf, Wren, & Carmichael, 2018).

Butler, G., Graaf, N. D., Wren, B., & Carmichael, P. (2018). Assessment and support of children and adolescents with gender dysphoria. Archives of Disease in Childhood. doi:10.1136/archdischild-2018-314992

Cohen, D., & Barnes, H. (2019). Gender dysphoria in children: Puberty blockers study draws further criticism. Bmj,L5647. doi:10.1136/bmj.l5647

Diagnostic and statistical manual of mental disorders: DSM-5. (2017). Arlington, VA: American Psychiatric Association.